Clinical Trial Update: A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose [Phase 1]

View source ↗

Summary

This Phase 1 study compares two concentrations of semaglutide at the 0.5 mg dose to assess comparability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• OZEMPIC (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2, Healthy Participants | Phase 1 | Status: COMPLETED